Nifty
:
23719.30
Sensex
:
75415.35
64.60 (0.27%)
231.99 (0.31%)
Nifty
Sensex
:
:
23719.30
75415.35
64.60 (0.27%)
231.99 (0.31%)

Krishna Institute of Medical Sciences Ltd

Hospital & Healthcare Services

Rating :
61/99

BSE: 543308 | NSE: KIMS

NSE BSE
764.10
22-May-2026
  • Open
  • High
  • Low
  • Previous Close
  •  773
  •  775
  •  757.15
  •  769.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  170196
  •  130677477.65
  •  798.4
  •  575.8

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 30,572.62
  • 126.65
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 33,741.92
  • N/A
  • 13.60

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 34.11%
  • 0.22%
  • 11.84%
  • FII
  • DII
  • Others
  • 14.57%
  • 32.00%
  • 7.26%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.48
  • 17.94
  • 11.36

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.97
  • 16.11
  • 5.76

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 30.55
  • 13.83
  • 4.56

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 51.01
  • 67.99

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 9.58
  • 10.66

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 28.00
  • 31.20

Earnings Forecasts:

(Updated: 23-05-2026)
Description
2024
2025
2026
2027
Adj EPS
6.83
11
17.69
21.84
P/E Ratio
111.87
69.46
43.19
34.99
Revenue
3874.02
5070.12
6133.81
6979.27
EBITDA
812.85
1120.69
1500.35
1773.91
Net Income
274.39
442.09
711.43
879.74
ROA
4.29
6.55
9.59
10.09
P/B Ratio
12.58
11.03
8.62
6.53
ROE
11.92
16.72
21.4
21.99
FCFF
-152.65
459.13
662.37
766.16
FCFF Yield
-0.44
1.32
1.91
2.21
Net Debt
2026.72
2450.83
2038.3
1254.9
BVPS
60.75
69.25
88.61
116.95

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
1,074.60
796.90
34.85%
997.70
772.40
29.17%
960.70
777.30
23.59%
871.60
688.40
26.61%
Expenses
868.10
598.90
44.95%
798.80
585.20
36.50%
756.70
559.20
35.32%
679.00
509.00
33.40%
EBITDA
206.50
198.00
4.29%
198.90
187.20
6.25%
204.00
218.10
-6.46%
192.60
179.40
7.36%
EBIDTM
19.22%
24.85%
19.94%
24.24%
21.23%
28.06%
22.10%
26.06%
Other Income
9.70
4.50
115.56%
5.20
17.80
-70.79%
4.20
5.00
-16.00%
7.10
4.60
54.35%
Interest
68.10
26.70
155.06%
56.80
25.70
121.01%
45.00
19.90
126.13%
32.60
17.90
82.12%
Depreciation
85.00
52.60
61.60%
78.70
44.70
76.06%
66.10
41.00
61.22%
53.40
39.00
36.92%
PBT
52.20
134.00
-61.04%
68.60
134.60
-49.03%
96.80
162.20
-40.32%
113.70
127.10
-10.54%
Tax
21.70
27.90
-22.22%
16.70
42.10
-60.33%
24.80
41.50
-40.24%
28.70
31.90
-10.03%
PAT
30.50
106.10
-71.25%
51.90
92.50
-43.89%
72.00
120.70
-40.35%
85.00
95.20
-10.71%
PATM
2.84%
13.31%
5.20%
11.98%
7.49%
15.53%
9.75%
13.83%
EPS
1.06
2.54
-58.27%
1.33
2.22
-40.09%
1.67
2.68
-37.69%
1.96
2.16
-9.26%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
3,904.60
3,035.10
2,498.20
2,197.68
1,650.83
1,329.94
1,122.64
918.00
663.67
567.14
511.82
Net Sales Growth
28.65%
21.49%
13.67%
33.13%
24.13%
18.47%
22.29%
38.32%
17.02%
10.81%
 
Cost Of Goods Sold
808.90
626.90
530.40
480.65
355.16
288.93
254.17
210.21
161.55
138.50
125.83
Gross Profit
3,095.70
2,408.20
1,967.80
1,717.03
1,295.67
1,041.01
868.48
707.80
502.12
428.64
386.00
GP Margin
79.28%
79.34%
78.77%
78.13%
78.49%
78.27%
77.36%
77.10%
75.66%
75.58%
75.42%
Total Expenditure
3,102.60
2,242.10
1,853.50
1,598.48
1,129.19
954.22
873.16
833.39
592.23
507.62
402.95
Power & Fuel Cost
-
52.20
49.00
43.69
25.83
24.31
24.29
20.64
16.65
14.18
13.68
% Of Sales
-
1.72%
1.96%
1.99%
1.56%
1.83%
2.16%
2.25%
2.51%
2.50%
2.67%
Employee Cost
-
499.50
422.40
346.44
261.91
220.21
198.05
163.03
121.71
98.11
80.72
% Of Sales
-
16.46%
16.91%
15.76%
15.87%
16.56%
17.64%
17.76%
18.34%
17.30%
15.77%
Manufacturing Exp.
-
898.90
715.80
597.29
420.59
366.51
336.25
277.05
23.33
20.54
149.25
% Of Sales
-
29.62%
28.65%
27.18%
25.48%
27.56%
29.95%
30.18%
3.52%
3.62%
29.16%
General & Admin Exp.
-
116.80
102.20
91.97
48.48
38.32
43.64
47.73
38.15
20.89
24.81
% Of Sales
-
3.85%
4.09%
4.18%
2.94%
2.88%
3.89%
5.20%
5.75%
3.68%
4.85%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
47.80
33.70
38.45
17.24
15.94
16.76
114.74
230.84
215.40
0.00
% Of Sales
-
1.57%
1.35%
1.75%
1.04%
1.20%
1.49%
12.50%
34.78%
37.98%
1.69%
EBITDA
802.00
793.00
644.70
599.20
521.64
375.72
249.48
84.61
71.44
59.52
108.87
EBITDA Margin
20.54%
26.13%
25.81%
27.27%
31.60%
28.25%
22.22%
9.22%
10.76%
10.49%
21.27%
Other Income
26.20
31.90
16.10
37.41
20.26
10.16
6.08
5.86
34.35
3.24
4.57
Interest
202.50
100.40
54.50
37.28
21.87
37.33
44.43
49.40
88.08
79.72
37.04
Depreciation
283.20
177.20
146.50
129.26
72.67
69.54
70.61
56.12
39.65
35.95
35.50
PBT
331.30
547.30
459.80
470.08
447.34
279.01
140.53
-15.04
-21.95
-52.92
40.90
Tax
91.90
143.30
123.60
119.09
113.06
73.54
25.45
33.54
25.85
17.88
12.93
Tax Rate
27.74%
25.68%
26.88%
24.56%
25.27%
26.36%
18.11%
-223.01%
-117.77%
-33.79%
31.61%
PAT
239.40
384.50
310.00
336.32
332.69
201.22
119.18
-47.66
-48.98
-70.80
26.74
PAT before Minority Interest
238.80
414.80
335.90
365.81
343.80
205.48
115.07
-48.59
-47.80
-70.80
27.97
Minority Interest
-0.60
-30.30
-25.90
-29.49
-11.11
-4.26
4.11
0.93
-1.18
0.00
-1.23
PAT Margin
6.13%
12.67%
12.41%
15.30%
20.15%
15.13%
10.62%
-5.19%
-7.38%
-12.48%
5.22%
PAT Growth
-42.24%
24.03%
-7.83%
1.09%
65.34%
68.84%
-
-
-
-
 
EPS
5.98
9.61
7.75
8.41
8.32
5.03
2.98
-1.19
-1.22
-1.77
0.67

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
2,137.80
1,828.20
1,669.54
1,387.31
863.73
598.13
540.59
-158.25
-113.16
263.36
Share Capital
80.00
80.00
80.03
80.03
77.59
74.49
74.49
50.15
50.15
70.40
Total Reserves
2,057.80
1,748.20
1,589.51
1,307.28
786.14
523.33
465.79
-208.40
-163.31
192.95
Non-Current Liabilities
2,421.10
1,274.80
666.67
278.49
278.70
364.23
347.03
301.86
243.67
221.16
Secured Loans
1,638.20
922.80
492.54
137.66
184.60
268.72
242.73
246.13
190.81
167.84
Unsecured Loans
15.90
4.90
4.90
0.00
0.00
0.00
0.00
2.71
7.88
6.39
Long Term Provisions
33.50
27.40
23.63
17.05
16.06
13.71
10.19
9.66
7.51
5.38
Current Liabilities
836.20
451.90
296.47
215.00
278.32
218.81
200.87
745.34
628.67
173.63
Trade Payables
269.10
196.70
174.25
129.53
131.87
123.43
104.06
94.96
79.16
66.84
Other Current Liabilities
408.90
145.10
88.60
73.20
72.00
77.92
63.68
618.77
534.85
87.25
Short Term Borrowings
130.20
91.50
19.55
1.76
55.27
10.11
17.55
30.51
11.68
16.62
Short Term Provisions
28.00
18.60
14.06
10.51
19.19
7.35
15.58
1.09
2.99
2.91
Total Liabilities
5,676.10
3,819.80
2,901.10
1,904.13
1,433.21
1,194.48
1,113.81
910.21
764.41
665.00
Net Block
3,348.50
2,433.90
1,766.32
1,005.21
931.08
915.98
863.09
710.99
522.63
514.52
Gross Block
4,089.20
3,019.20
2,197.96
1,329.42
1,190.02
1,106.30
991.64
796.09
558.54
679.17
Accumulated Depreciation
740.70
585.30
431.64
324.21
258.94
190.33
128.55
85.10
35.91
164.65
Non Current Assets
4,978.80
3,272.50
2,423.47
1,510.74
982.02
974.64
939.96
754.23
618.56
550.00
Capital Work in Progress
1,213.80
600.10
476.93
20.76
9.24
2.23
0.23
0.00
63.60
2.39
Non Current Investment
77.10
74.40
0.00
332.48
0.00
0.00
0.00
0.00
15.15
10.88
Long Term Loans & Adv.
310.50
157.80
171.88
148.73
34.79
55.02
72.65
40.49
15.99
21.45
Other Non Current Assets
28.90
6.30
8.33
3.56
6.91
1.42
3.98
2.75
1.18
0.77
Current Assets
697.30
547.30
477.64
393.40
451.19
219.83
173.85
155.97
145.85
114.99
Current Investments
22.00
82.90
67.89
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
64.00
49.40
42.87
36.43
24.09
30.38
26.86
20.14
16.41
12.31
Sundry Debtors
395.40
294.40
252.65
128.64
109.82
132.27
123.27
107.53
81.34
66.47
Cash & Bank
79.70
49.00
66.37
190.06
284.44
45.73
10.20
11.35
8.41
6.85
Other Current Assets
136.20
8.10
5.03
5.02
32.85
11.46
13.52
16.96
39.70
29.36
Short Term Loans & Adv.
124.20
63.50
42.83
33.24
19.97
10.10
12.51
15.73
38.79
28.02
Net Current Assets
-138.90
95.40
181.17
178.39
172.87
1.02
-27.02
-589.36
-482.82
-58.64
Total Assets
5,676.10
3,819.80
2,901.11
1,904.14
1,433.21
1,194.47
1,113.81
910.20
764.41
664.99

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Cash From Operating Activity
581.80
521.20
432.09
324.02
355.97
201.50
PBT
558.10
459.50
484.91
456.85
279.01
140.53
Adjustment
242.00
186.20
113.70
68.54
100.56
114.53
Changes in Working Capital
-76.90
15.70
-69.28
-74.47
14.15
0.12
Cash after chg. in Working capital
723.20
661.40
529.32
450.92
393.72
255.17
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-141.40
-140.20
-97.23
-126.90
-37.74
-53.67
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-1,116.20
-752.60
-546.89
-411.52
-354.18
-124.71
Net Fixed Assets
-385.50
-395.01
-64.99
-57.47
-68.27
Net Investments
-163.50
-236.26
-284.03
-328.79
-35.26
Others
-567.20
-121.33
-197.87
-25.26
-250.65
Cash from Financing Activity
543.10
216.70
19.64
61.00
9.82
-44.34
Net Cash Inflow / Outflow
8.70
-14.70
-95.17
-26.50
11.62
32.45
Opening Cash & Equivalents
46.90
61.60
25.63
52.13
40.51
8.06
Closing Cash & Equivalent
56.00
46.90
61.61
25.63
52.13
40.51

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Book Value (Rs.)
53.45
45.70
41.72
173.35
111.32
80.25
ROA
8.74%
10.00%
15.23%
20.60%
15.64%
9.97%
ROE
20.92%
19.21%
23.93%
30.55%
28.12%
20.22%
ROCE
19.04%
20.25%
27.84%
35.69%
30.82%
21.17%
Fixed Asset Turnover
0.85
0.96
1.25
1.31
1.16
1.07
Receivable days
41.48
39.96
31.66
26.36
33.22
41.54
Inventory Days
6.82
6.74
6.58
6.69
7.47
9.30
Payable days
135.60
127.64
115.35
134.33
161.26
46.79
Cash Conversion Cycle
-87.31
-80.93
-77.10
-101.27
-120.57
4.06
Total Debt/Equity
0.89
0.57
0.32
0.12
0.31
0.54
Interest Cover
6.56
9.43
14.01
21.89
8.47
4.16

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Krishna Institute inks pact to take 2 acres of land on lease in Andhra Pradesh
    9th May 2026, 10:54 AM

    The proposed multi-speciality hospital will offer comprehensive tertiary and quaternary care across cardiology, oncology, neurosciences

    Read More
  • Krishna Institute sings agreement with Dakshayani Healthcare Services
    23rd Apr 2026, 16:30 PM

    KIMS will benefit from and foster the collaborative development of clinical protocols and treatment methodologies with Renova

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.